Meet The Corporate Sponsors Paying For Obama's Inauguration

Business Insider

President Barack Obama will be inaugurated for his second term on Jan. 21, an expensive event run and funded by the Presidential Inaugural Committee.

For his second inauguration, Obama has authorized the group preparing for inauguration to accept contributions from corporate sponsors. 

Though documents filed with the FEC will eventually reveal the full list of donors and the exact amounts contributed, the 2013 Presidential Inaugural Committee has released a partial list of donors. 

Major corporate donors include Microsoft and AT&T.

The only other listed companies are health care company the Centene Corporation, marketer Financial Innovations, Inc, genetic research firm Genentech Inc, Stream Line Circle LLC and investment firm Whittier Trust Company.

Obama's previous inauguration was the largest event to ever take place in the District of Columbia. It was also a lavish affair, costing $170 million that was raised entirely and strictly from individual donors. Obama also banned corporate donations at the Democratic National Convention in Charlotte last September.

See the list of corporate and individual donors here >



More From Business Insider

Rates

View Comments (2)

Recommended for You

  • Apple's iPhone sales beat Street but iPad volumes slide

    Apple Inc (AAPL.O) forecast a strong holiday quarter after a better-than-expected 16 percent jump in iPhone sales, and the strongest growth in Mac computer shipments in years helped the company surpass Wall Street's targets. The company on Monday projected stronger-than-expected revenue of $63.5 billion to $66.5 billion in the December quarter, when new iPads and iPhones vie with rival devices from Microsoft Corp (MSFT.O) and Amazon.com Inc (AMZN.O) for consumers' holiday outlays. Shares of Apple rose 1.3 percent to about $101.10 in after-hours trade. A gradual decline in tablet demand worldwide has worried investors already concerned with Apple's slowing growth, who are awaiting a new device that can energize its expansion.

    4 mins ago
  • The Invention That Saved America

    The US is back on top, and this new technology is bringing manufacturing back onshore.

    AdChoicesThe Motley FoolSponsored
  • Asian shares crawl higher on China GDP relief

    Asian stocks crept up on Tuesday as investors took solace from data showing the Chinese economy grew slightly more than expected in the third quarter, calming fears of a deepening slowdown in the world's second-largest economy. China's economy grew 7.3 percent between July and September from a year earlier, slightly above expectations. It also shows that we don't need to be that concerned about the depth of slow down in China," said Dariusz Kowalczyk at Credit Agricole Corporate and Investment Bank in Hong Kong. MSCI's broadest index of Asia-Pacific shares outside Japan rose about 0.3 percent in morning trade following the Chinese figures, after opening flat.

    4 mins ago
  • China posts slowest growth since global crisis, more stimulus expected

    China's economic growth slowed in the third quarter to its weakest since the 2008/09 global financial crisis as a slumping property market dragged on manufacturing and investment, adding to concerns about flagging global growth. The slowdown reinforced expectations that Beijing will need to unveil more stimulus measures to avert a sharper slowdown, though analysts appeared divided over whether policymakers would continue to roll out more modest support steps or take more aggressive action such as cutting interest rates. The weaker gross domestic product figure fed speculation that China will miss its official full-year growth target of 7.5 percent, even though Premier Li Keqiang has stated repeatedly that the country can tolerate slightly lower growth. Li has instead indicated that the leadership's bottom line is maintaining robust employment levels to ward off social unrest, a policy priority for China's stability-obsessed Communist government.

    4 mins ago
  • Staples says investigating possible payment card data breach

    "Staples is in the process of investigating a potential issue involving credit card data and has contacted law enforcement," company spokesman Mark Cautela said in a statement.  "If Staples discovers an issue, it is important to note that customers are not responsible for any fraudulent activity on their credit cards that is reported on a timely basis." The office supply retailer disclosed the investigation after security reporter Brian Krebs reported on his blog Krebsonsecurity.com that several banks have identified a pattern of payment card fraud suggesting that several Staples stores in northeastern United States had succumbed to a data breach.

    4 mins ago
  • Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant

    Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was making a hostile takeover bid, court documents showed. Ackman's hedge fund has been working with Valeant for months to craft a deal for Valeant to buy Allergan, but Allergan has rejected all of Valeant's overtures and tried to find other potential partners to avoid a deal. In the filing with the federal court in Santa Ana, California, lawyers said that Pyott provided false and misleading information about Valeant to investors, failed to disclose Allergan CFO Jeff Edward's resignation in a timely manner, and ignored outside advisors' input when he falsely called Valeant's account "opaque" and "problematic."

    4 mins ago
  • AbbVie says $55 billion acquisition of Shire officially dead

    AbbVie, which last week said its board of directors had withdrawn its recommendation to proceed with the Shire purchase, blamed the unraveling on last month's rules changes by the U.S. The company's Chief Executive, Richard Gonzalez, on a conference call with investors, said the new rules and possible future changes "created an environment of risk and uncertainty which makes proceeding not in the best interest of our shareholders." In addition to tax benefits, the acquisition would have given AbbVie Shire's portfolio of lucrative medicines for rare diseases and other specialty drugs, lessening the Chicago-based company's dependence on its rheumatoid arthritis treatment Humira - currently the world's top selling drug with annual sales approaching $13 billion.

    4 mins ago
  • China to pitch high-speed trains to California

    State-backed China CNR Corporation is making a pitch to sell its high-speed trains to California, signaling China's growing export ambitions for such technology after building the world's longest network in just seven years. It marks the first concrete attempt by China to sell high-speed locomotives abroad and establish itself as a credible rival to sector leaders such as Germany's Siemens, Canada's Bombardier and Japan's Kawasaki. CNR, its unit Tangshan Railway and U.S.-based SunGroup USA are submitting an expression of interest to California's $68 billion high-speed rail project for a contract to supply up to 95 trains that can travel as fast as 354 kilometers per hour (221 miles per hour), SunGroup told Reuters. "We believe that high-speed rail is something that China does very well, and it's a product that we can export across the world," SunGroup spokesman Jonathan Sun said in a phone interview, adding that SunGroup, CNR and Tangshan Railway had been working together for four years.

    4 mins ago
  • Often Overlooked Method to Pay Off Mortgage

    If you own a home and pay for a mortgage, you could reduce your payments by an average of $4,100 a year. Here is how it works.

    AdChoicesRateMarketplaceSponsored
  • Valeant says may raise Allergan bid; beats on profit

    Valeant CEO Michael Pearson said a possible revised stock and cash bid would be worth more than $200 per share, assuming that Valeant's stock rises, and would include more cash. Allergan stock was up 1.7 percent at $180.45. Valeant's third-quarter results were keenly anticipated for their potential impact on Valeant's bid for Allergan, maker of anti-wrinkle injection Botox. Unlike most quarters in which, according to critics, one-time charges related to acquisitions obscure Valeant's performance, the company made few deals as it stalked Allergan.

    4 mins ago
  • Top Allergan holder Paulson urges deal with Shire: sources

    The hedge fund, which earlier supported a deal with Valeant, told Allergan CEO David Pyott that it would now support a deal with Shire, the sources said. It was not immediately clear whether Allergan would pursue such a deal. Paulson had a 1.9 percent stake in Allergan, making it one of the company's top 10 shareholders, according to Thomson Reuters data as of June 30. Paulson was also Shire's third-largest shareholder, according to the data.

    4 mins ago
  • UPS says U.S. rates to rise 4.9 percent as of December 29

    Package delivery company United Parcel Service Inc said on Monday that rates for its services within and between the United States, Canada and Puerto Rico will rise by an average of 4.9 percent as of the ...

    4 mins ago